MyFinsight
Home
Blog
About
Contact
Marketable securities
$241,289K
Cash and cash
equivalents
$134,697K
Prepaid expenses and
other current assets
$81,332K
Accounts receivable
$9,131K
Restricted cash
equivalents, long-term
$15,404K
Other investments
$11,424K
Investment in kyverna
$10,130K
Prepaid expenses and
other assets,...
$1,052K
Total current assets
$466,449K
Marketable securities -
noncurrent
$141,261K
Operating lease
right-of-use assets
$97,543K
Investments and other assets
$38,010K
Property and equipment,
net
$15,516K
Total assets
$758,779K
Total liabilities and
stockholders' equity
$758,779K
Total stockholders
equity
$620,939K
Total liabilities
$137,840K
Accumulated deficit
-$2,686,325K
Accumulated other
comprehensive income
-$240K
Additional paid-in capital
$3,307,492K
Total current
liabilities
$76,445K
Long-term operating lease
liability
$61,395K
Common stock, 0.0001
par value...
$12K
Accrued expenses
$37,920K
Current portion of
operating lease liability
$19,095K
Accounts payable
$18,800K
Current portion of
deferred revenue
$630K
Accrued research and
development
$11,790K
Employee compensation
and benefits
$9,323K
Accrued legal and
professional expenses
$8,703K
Accrued other
$8,104K
Back
Back
Balance Sheet
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)
source: myfinsight.com